| Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease L Jostins, S Ripke, RK Weersma, RH Duerr, DP McGovern, KY Hui, ... Nature 491 (7422), 119-124, 2012 | 5469 | 2012 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10285), 1637-1645, 2021 | 906* | 2021 |
| Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study I Cleynen, G Boucher, L Jostins, LP Schumm, S Zeissig, T Ahmad, ... The Lancet 387 (10014), 156-167, 2016 | 896 | 2016 |
| Crohn's disease management after intestinal resection: a randomised trial P De Cruz, MA Kamm, AL Hamilton, KJ Ritchie, EO Krejany, A Gorelik, ... The Lancet 385 (9976), 1406-1417, 2015 | 671 | 2015 |
| International IBD Genetics Consortium (IIBDGC). Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease L Jostins, S Ripke, RK Weersma, RH Duerr, DP McGovern, KY Hui, ... Nature 491 (7422), 119-124, 2012 | 652 | 2012 |
| The Pluto system: Initial results from its exploration by New Horizons SA Stern, F Bagenal, K Ennico, GR Gladstone, WM Grundy, ... Science 350 (6258), aad1815, 2015 | 468 | 2015 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10325), 665-676, 2022 | 429* | 2022 |
| Concentrations of adalimumab and infliximab in mothers and newborns, and effects on infection M Julsgaard, LA Christensen, PR Gibson, RB Gearry, J Fallingborg, ... Gastroenterology 151 (1), 110-119, 2016 | 369 | 2016 |
| High-density mapping of the MHC identifies a shared role for HLA-DRB1* 01: 03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis P Goyette, G Boucher, D Mallon, E Ellinghaus, L Jostins, H Huang, ... Nature genetics 47 (2), 172-179, 2015 | 363 | 2015 |
| Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery EK Wright, MA Kamm, P De Cruz, AL Hamilton, KJ Ritchie, EO Krejany, ... Gastroenterology 148 (5), 938-947. e1, 2015 | 345 | 2015 |
| Linezolid resistance in clinical isolates of Staphylococcus aureus P Wilson, JA Andrews, R Charlesworth, R Walesby, M Singer, DJ Farrell, ... Journal of Antimicrobial Chemotherapy 51 (1), 186-188, 2003 | 342 | 2003 |
| Effects of age on concentrations of plasma cholecystokinin, glucagon-like peptide 1, and peptide YY and their relation to appetite and pyloric motility CG MacIntosh, JM Andrews, KL Jones, JM Wishart, HA Morris, ... The American journal of clinical nutrition 69 (5), 999-1006, 1999 | 318 | 1999 |
| consensus statements on therapeutic drug monitoring of anti‐tumour necrosis factor therapy in inflammatory bowel diseases N Mitrev, N Vande Casteele, CH Seow, JM Andrews, SJ Connor, ... Alimentary pharmacology & therapeutics 46 (11-12), 1037-1053, 2017 | 303* | 2017 |
| Fear and fertility in inflammatory bowel disease: a mismatch of perception and reality affects family planning decisions R Mountifield, P Bampton, R Prosser, K Muller, JM Andrews Inflammatory bowel diseases 15 (5), 720-725, 2009 | 287 | 2009 |
| Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review AA Mikocka-Walus, DA Turnbull, NT Moulding, IG Wilson, JM Andrews, ... Inflammatory bowel diseases 13 (2), 225-234, 2007 | 266 | 2007 |
| Effects of fat digestion on appetite, APD motility, and gut hormones in response to duodenal fat infusion in humans C Feinle, D O'Donovan, S Doran, JM Andrews, J Wishart, I Chapman, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 284 (5 …, 2003 | 242 | 2003 |
| Female gender and surgery impair relationships, body image, and sexuality in inflammatory bowel disease: patient perceptions KR Muller, R Prosser, P Bampton, R Mountifield, JM Andrews Inflammatory bowel diseases 16 (4), 657-663, 2010 | 229 | 2010 |
| HLA-DQA1–HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants GA Heap, MN Weedon, CM Bewshea, A Singh, M Chen, JB Satchwell, ... Nature genetics 46 (10), 1131-1134, 2014 | 223 | 2014 |
| Systematic review: body composition in adults with inflammatory bowel disease RV Bryant, MJ Trott, FD Bartholomeusz, JM Andrews Alimentary pharmacology & therapeutics 38 (3), 213-225, 2013 | 218 | 2013 |
| Sensory neuro-immune interactions differ between irritable bowel syndrome subtypes PA Hughes, AM Harrington, J Castro, T Liebregts, B Adam, DJ Grasby, ... Gut 62 (10), 1456-1465, 2013 | 212 | 2013 |
